Zobrazeno 1 - 10
of 72
pro vyhledávání: '"C Fabères"'
Autor:
Francois-Xavier Mahon, Marie-Pierre Fort, Béatrice Turcq, Laura Versmée, François Lifermann, Fanny Robbesyn, Marius Moldovan, Gabriel Etienne, Anais Charles-Nelson, Didier Adiko, Caroline Lenoir, Axelle Lascaux, Anna Schmitt, C. Fabères, Frédéric Bauduer, Stéphanie Dulucq, Emilie Klein, Sandrine Katsahian, Françoise Durrieu, Fontanet Bijou, Corinne Dagada, Samia Madene
Publikováno v:
Cancer Medicine, Vol 10, Iss 11, Pp 3635-3645 (2021)
Cancer Medicine
Cancer Medicine, Wiley, 2021, 10 (11), pp.3635-3645. ⟨10.1002/cam4.3921⟩
Cancer Medicine, Wiley, In press, ⟨10.1002/cam4.3921⟩
Cancer Medicine, In press, ⟨10.1002/cam4.3921⟩
Cancer Medicine
Cancer Medicine, Wiley, 2021, 10 (11), pp.3635-3645. ⟨10.1002/cam4.3921⟩
Cancer Medicine, Wiley, In press, ⟨10.1002/cam4.3921⟩
Cancer Medicine, In press, ⟨10.1002/cam4.3921⟩
Background Tyrosine kinase inhibitors (TKI) can be safely discontinued in chronic phase chronic myeloid leukemia (CP‐CML) patients who had achieved a sustained deep molecular response. Based on the results of discontinuation trials, recommendations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fca751c46258b429147e6b00f8e3770e
https://doaj.org/article/e95e922c9ffa45b69d31d079ecb40d5f
https://doaj.org/article/e95e922c9ffa45b69d31d079ecb40d5f
Autor:
Laura Versmée, Emilie Klein, Caroline Lenoir, Fanny Robbesyn, Sandrine Katsahian, Marie-Pierre Fort, Anna Schmitt, Axelle Lascaux, François Lifermann, Gabriel Etienne, Françoise Durrieu, Fontanet Bijou, Francois-Xavier Mahon, Stéphanie Dulucq, C. Fabères, Béatrice Turcq, Samia Madene, Marius Moldovan, Corinne Dagada, Didier Adiko, Frédéric Bauduer
Publikováno v:
Cancers
Cancers, MDPI, 2020, 12 (9), pp.2521. ⟨10.3390/cancers12092521⟩
Volume 12
Issue 9
Cancers, 2020, 12 (9), pp.2521. ⟨10.3390/cancers12092521⟩
Cancers, Vol 12, Iss 2521, p 2521 (2020)
Cancers, MDPI, 2020, 12 (9), pp.2521. ⟨10.3390/cancers12092521⟩
Volume 12
Issue 9
Cancers, 2020, 12 (9), pp.2521. ⟨10.3390/cancers12092521⟩
Cancers, Vol 12, Iss 2521, p 2521 (2020)
Background: Tyrosine Kinase Inhibitors (TKIs) discontinuation in patients who had achieved a deep molecular response (DMR) offer now the opportunity of prolonged treatment-free remission (TFR). Patients and Methods: Aims of this study were to evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62f9d97d5ba853e309b57d447f7596e0
https://hal.archives-ouvertes.fr/hal-03085198/document
https://hal.archives-ouvertes.fr/hal-03085198/document
Autor:
Stéphanie Dulucq, Emilie Klein, Anna Schmitt, Gabriel Etienne, Marie-Pierre Fort, Françoise Durrieu, Fontanet Bijou, Emilie Toulza, Francois-Xavier Mahon, C. Fabères
Publikováno v:
British Journal of Haematology. 189
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ce0468dfb0fadafffadb00f63defaba
https://doi.org/10.1111/bjh.16511
https://doi.org/10.1111/bjh.16511
Autor:
V. De Ledinghen, Juliette Foucher, S Duc, G Hou, C Fabères, Faiza Chermak, N Souakri, A Lafournière, F Chenus, J. Vergniol, Jean-Baptiste Hiriart
Publikováno v:
International journal of impotence research. 28(2)
Chronic hepatitis C (CHC) patients often have altered quality of life. Few data are available about sexual impairment (SI) in CHC. From 2011 to 2013, we included consecutive CHC outpatients. Exclusion criteria were: antiviral therapy, co-infection, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cd79df18ed1f6b476c1638889ec09c8
https://pubmed.ncbi.nlm.nih.gov/26865102
https://pubmed.ncbi.nlm.nih.gov/26865102
Autor:
F X, Mahon, X, Delbrel, P, Cony-Makhoul, C, Fabères, J M, Boiron, C, Barthe, C, Bilhou-Nabéra, A, Pigneux, G, Marit, J, Reiffers
Publikováno v:
Journal of Clinical Oncology. 20:214-220
PURPOSE: A small proportion of patients with chronic myeloid leukemia (CML) achieve a complete cytogenetic response (CCR), defined as the disappearance of Philadelphia (Ph) chromosome–positive metaphases, after treatment with interferon alfa (IFN).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16f92ccb5a7ddd2ce918ffd1701a4b57
https://doi.org/10.1200/jco.2002.20.1.214
https://doi.org/10.1200/jco.2002.20.1.214
Autor:
D. Blaise, C. Fabères, Dominique Maraninchi, Pascale Cony-Makhoul, J. M. Boiron, F. Bauduer, Christian Chabannon, Josy Reiffers, A M Stoppa, D. Redortier, Arnaud Pigneux, G. Marit
Publikováno v:
Hematology and Cell Therapy. 42:135-141
Thirty-two patients < 55 year with AML in first complete remission underwent autologous peripheral blood stem cell transplantation (PBSCT). Before transplant, they were treated with one or two induction courses plus one consolidation cycle including
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a8e4db23521b495f6dad4e4b8813c22
https://doi.org/10.1007/s00282-000-0135-8
https://doi.org/10.1007/s00282-000-0135-8
Autor:
A. Carrère, Chrystele Bilhou-Nabera, S. Pueyo, G. Marit, Mahon Fx, Jean-Michel Boiron, Pascale Cony-Makhoul, R. Salmi, M. Montastruc, Josy Reiffers, P. Bernard, Arnaud Pigneux, C. Fabères
Publikováno v:
Blood. 92:4059-4065
In a single institution, we have used recombinant interferon- (IFN-) to treat 116 newly diagnosed Philadelphia-positive (Ph+) chronic myeloid leukemia (CML) patients and analyzed the predictive factors for response and survival. The patients wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55e6d3ffa93e7cbbc8211e22aac46c1a
https://doi.org/10.1182/blood.v92.11.4059
https://doi.org/10.1182/blood.v92.11.4059
Autor:
M. Puntous, Jean-Michel Boiron, G. Vezon, A.M. Ferrer, G. Marit, C. Fabères, P. Bernard, A. Broustet, C. Foures, Josy Reiffers, Pascale Cony-Makhoul
Publikováno v:
Journal of Hematotherapy. 3:185-191
We retrospectively studied the factors affecting the rate of hematopoietic reconstitution (HR) in 118 patients with hematological malignancies who underwent peripheral blood progenitor cell (PBPC) transplantation at a single institution. The patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::368956d3202d15f97f51af0d82cc616b
https://doi.org/10.1089/scd.1.1994.3.185
https://doi.org/10.1089/scd.1.1994.3.185
Autor:
G. Vezon, Chrystele Bilhou-Nabera, M. Montastruc, Antoine Broustet, C. Fabères, Pascale Cony-Makhoul, Josy Reiffers, P. Bernard, G. Marit, Gharbi Mj
Publikováno v:
Leukemia & Lymphoma. 11:297-299
Autologous blood stem cell transplantation (ASCT) was performed in 32 patients with high risk chronic myelogenous leukemia (CML). Prior to ASCT, the patients were given Busulfan and high-dose Melphalan. Peripheral blood stem cells collected at diagno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1120275088462a862b7fe56e434a0b5f
https://doi.org/10.3109/10428199309047902
https://doi.org/10.3109/10428199309047902
Autor:
Jean-Jacques Sotto, Michel Attal, Josy Reiffers, Jean-Albert Gastaut, Jean-Michel Boiron, O Boulat, C. Fabères, R Bouabdallaha, Nathalie Fegueux, D. Maraninchi, Eric Jourdan, Didier Blaise, Stoppa Am, G. Marit, Nicole Dastugue
Publikováno v:
Leukemialymphoma. 42(1-2)
Between 50 and 75% of adult patients with de novo acute myeloid leukemia achieve complete remission (CR) but 25 to 40% of them require more than one course of induction chemotherapy to achieve CR. In order to investigate the impact of this situation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44729dccea782d01f6a25666cf348993
https://pubmed.ncbi.nlm.nih.gov/11699222
https://pubmed.ncbi.nlm.nih.gov/11699222